GNF SymAtlas + NCI-60 cancer cell lines, comparison of cancers vs non-cancers, human (Su, 2004; Ross, 2000)
Name | miRBASE accession |
---|---|
hsa-miR-143-3p
|
MIMAT0000435 |
hsa-miR-4770
|
MIMAT0019924 |
hsa-miR-6088
|
MIMAT0023713 |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chrX_-_106959631 | 5.61 |
ENST00000486554.1
ENST00000372390.4 |
TSC22D3
|
TSC22 domain family, member 3 |
chr11_+_113930291 | 5.27 |
ENST00000335953.4
|
ZBTB16
|
zinc finger and BTB domain containing 16 |
chr13_+_48807288 | 3.91 |
ENST00000378565.5
|
ITM2B
|
integral membrane protein 2B |
chr15_+_74833518 | 3.88 |
ENST00000346246.5
|
ARID3B
|
AT rich interactive domain 3B (BRIGHT-like) |
chr19_+_18942720 | 3.35 |
ENST00000262803.5
|
UPF1
|
UPF1 regulator of nonsense transcripts homolog (yeast) |
chr17_+_19281034 | 2.97 |
ENST00000308406.5
ENST00000299612.7 |
MAPK7
|
mitogen-activated protein kinase 7 |
chr15_+_31619013 | 2.18 |
ENST00000307145.3
|
KLF13
|
Kruppel-like factor 13 |
chr1_-_57045228 | 1.97 |
ENST00000371250.3
|
PPAP2B
|
phosphatidic acid phosphatase type 2B |
chr1_-_205290865 | 1.93 |
ENST00000367157.3
|
NUAK2
|
NUAK family, SNF1-like kinase, 2 |
chr2_-_217560248 | 1.93 |
ENST00000233813.4
|
IGFBP5
|
insulin-like growth factor binding protein 5 |
chr19_-_13617247 | 1.88 |
ENST00000573710.2
|
CACNA1A
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
chr5_+_142149955 | 1.88 |
ENST00000378004.3
|
ARHGAP26
|
Rho GTPase activating protein 26 |
chr17_+_47865917 | 1.83 |
ENST00000259021.4
ENST00000454930.2 ENST00000509773.1 ENST00000510819.1 ENST00000424009.2 |
KAT7
|
K(lysine) acetyltransferase 7 |
chr4_+_87856129 | 1.80 |
ENST00000395146.4
ENST00000507468.1 |
AFF1
|
AF4/FMR2 family, member 1 |
chr18_+_9136758 | 1.74 |
ENST00000383440.2
ENST00000262126.4 ENST00000577992.1 |
ANKRD12
|
ankyrin repeat domain 12 |
chr15_+_85923856 | 1.73 |
ENST00000560302.1
ENST00000394518.2 ENST00000361243.2 ENST00000560256.1 |
AKAP13
|
A kinase (PRKA) anchor protein 13 |
chr12_+_11802753 | 1.67 |
ENST00000396373.4
|
ETV6
|
ets variant 6 |
chr22_+_40390930 | 1.62 |
ENST00000333407.6
|
FAM83F
|
family with sequence similarity 83, member F |
chr16_-_79634595 | 1.45 |
ENST00000326043.4
ENST00000393350.1 |
MAF
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog |
chr14_-_96830207 | 1.45 |
ENST00000359933.4
|
ATG2B
|
autophagy related 2B |
chr7_+_20370746 | 1.43 |
ENST00000222573.4
|
ITGB8
|
integrin, beta 8 |
chr3_+_9975497 | 1.39 |
ENST00000397170.3
ENST00000383811.3 ENST00000452070.1 ENST00000326434.5 |
CRELD1
|
cysteine-rich with EGF-like domains 1 |
chr19_-_19739007 | 1.38 |
ENST00000586703.1
ENST00000591042.1 ENST00000407877.3 |
LPAR2
|
lysophosphatidic acid receptor 2 |
chr2_+_45878790 | 1.35 |
ENST00000306156.3
|
PRKCE
|
protein kinase C, epsilon |
chr15_+_65134088 | 1.32 |
ENST00000323544.4
ENST00000437723.1 |
PLEKHO2
AC069368.3
|
pleckstrin homology domain containing, family O member 2 Uncharacterized protein |
chr2_+_28615669 | 1.31 |
ENST00000379619.1
ENST00000264716.4 |
FOSL2
|
FOS-like antigen 2 |
chr16_+_50187556 | 1.30 |
ENST00000561678.1
ENST00000357464.3 |
PAPD5
|
PAP associated domain containing 5 |
chr5_+_32711419 | 1.27 |
ENST00000265074.8
|
NPR3
|
natriuretic peptide receptor C/guanylate cyclase C (atrionatriuretic peptide receptor C) |
chr11_-_73309228 | 1.24 |
ENST00000356467.4
ENST00000064778.4 |
FAM168A
|
family with sequence similarity 168, member A |
chr15_-_26108355 | 1.20 |
ENST00000356865.6
|
ATP10A
|
ATPase, class V, type 10A |
chr5_-_100238956 | 1.18 |
ENST00000231461.5
|
ST8SIA4
|
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4 |
chr1_-_179198702 | 1.17 |
ENST00000502732.1
|
ABL2
|
c-abl oncogene 2, non-receptor tyrosine kinase |
chr14_+_101193164 | 1.15 |
ENST00000341267.4
|
DLK1
|
delta-like 1 homolog (Drosophila) |
chr6_-_132272504 | 1.12 |
ENST00000367976.3
|
CTGF
|
connective tissue growth factor |
chr8_+_102504651 | 1.12 |
ENST00000251808.3
ENST00000521085.1 |
GRHL2
|
grainyhead-like 2 (Drosophila) |
chr1_+_62208091 | 1.09 |
ENST00000316485.6
ENST00000371158.2 |
INADL
|
InaD-like (Drosophila) |
chr2_-_25475120 | 1.05 |
ENST00000380746.4
ENST00000402667.1 |
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha |
chr9_-_123476719 | 1.02 |
ENST00000373930.3
|
MEGF9
|
multiple EGF-like-domains 9 |
chr15_-_49338748 | 1.01 |
ENST00000559471.1
|
SECISBP2L
|
SECIS binding protein 2-like |
chr12_+_69864129 | 1.00 |
ENST00000547219.1
ENST00000299293.2 ENST00000549921.1 ENST00000550316.1 ENST00000548154.1 ENST00000547414.1 ENST00000550389.1 ENST00000550937.1 ENST00000549092.1 ENST00000550169.1 |
FRS2
|
fibroblast growth factor receptor substrate 2 |
chr17_-_48278983 | 0.99 |
ENST00000225964.5
|
COL1A1
|
collagen, type I, alpha 1 |
chrX_+_133507327 | 0.99 |
ENST00000332070.3
ENST00000394292.1 ENST00000370799.1 ENST00000416404.2 |
PHF6
|
PHD finger protein 6 |
chr14_+_21538429 | 0.93 |
ENST00000298694.4
ENST00000555038.1 |
ARHGEF40
|
Rho guanine nucleotide exchange factor (GEF) 40 |
chr6_+_32709119 | 0.91 |
ENST00000374940.3
|
HLA-DQA2
|
major histocompatibility complex, class II, DQ alpha 2 |
chr8_-_63998590 | 0.89 |
ENST00000260116.4
|
TTPA
|
tocopherol (alpha) transfer protein |
chr5_+_169064245 | 0.87 |
ENST00000256935.8
|
DOCK2
|
dedicator of cytokinesis 2 |
chr4_+_55095264 | 0.87 |
ENST00000257290.5
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide |
chr2_-_96931679 | 0.86 |
ENST00000258439.3
ENST00000432959.1 |
TMEM127
|
transmembrane protein 127 |
chr15_+_39873268 | 0.86 |
ENST00000397591.2
ENST00000260356.5 |
THBS1
|
thrombospondin 1 |
chr3_+_9834758 | 0.84 |
ENST00000485273.1
ENST00000433034.1 ENST00000397256.1 |
ARPC4
ARPC4-TTLL3
|
actin related protein 2/3 complex, subunit 4, 20kDa ARPC4-TTLL3 readthrough |
chr19_-_10121144 | 0.81 |
ENST00000264828.3
|
COL5A3
|
collagen, type V, alpha 3 |
chr9_-_35650900 | 0.80 |
ENST00000259608.3
|
SIT1
|
signaling threshold regulating transmembrane adaptor 1 |
chr11_-_118661828 | 0.77 |
ENST00000264018.4
|
DDX6
|
DEAD (Asp-Glu-Ala-Asp) box helicase 6 |
chr2_+_233562015 | 0.72 |
ENST00000427233.1
ENST00000373566.3 ENST00000373563.4 ENST00000428883.1 ENST00000456491.1 ENST00000409480.1 ENST00000421433.1 ENST00000425040.1 ENST00000430720.1 ENST00000409547.1 ENST00000423659.1 ENST00000409196.3 ENST00000409451.3 ENST00000429187.1 ENST00000440945.1 |
GIGYF2
|
GRB10 interacting GYF protein 2 |
chr18_-_29522989 | 0.70 |
ENST00000582539.1
ENST00000283351.4 ENST00000582513.1 |
TRAPPC8
|
trafficking protein particle complex 8 |
chr16_+_70148230 | 0.69 |
ENST00000398122.3
ENST00000568530.1 |
PDPR
|
pyruvate dehydrogenase phosphatase regulatory subunit |
chr17_+_60704762 | 0.69 |
ENST00000303375.5
|
MRC2
|
mannose receptor, C type 2 |
chrX_+_9983602 | 0.66 |
ENST00000380861.4
|
WWC3
|
WWC family member 3 |
chr10_+_76871454 | 0.66 |
ENST00000372687.4
|
SAMD8
|
sterile alpha motif domain containing 8 |
chr7_-_42276612 | 0.66 |
ENST00000395925.3
ENST00000437480.1 |
GLI3
|
GLI family zinc finger 3 |
chr3_-_24536253 | 0.65 |
ENST00000428492.1
ENST00000396671.2 ENST00000431815.1 ENST00000418247.1 ENST00000416420.1 ENST00000356447.4 |
THRB
|
thyroid hormone receptor, beta |
chr16_+_66400533 | 0.64 |
ENST00000341529.3
|
CDH5
|
cadherin 5, type 2 (vascular endothelium) |
chr10_-_105615164 | 0.59 |
ENST00000355946.2
ENST00000369774.4 |
SH3PXD2A
|
SH3 and PX domains 2A |
chr13_-_33002151 | 0.59 |
ENST00000495479.1
ENST00000343281.4 ENST00000464470.1 ENST00000380139.4 ENST00000380133.2 |
N4BP2L1
|
NEDD4 binding protein 2-like 1 |
chr5_+_141303373 | 0.57 |
ENST00000432126.2
ENST00000194118.4 |
KIAA0141
|
KIAA0141 |
chr19_-_14629224 | 0.57 |
ENST00000254322.2
|
DNAJB1
|
DnaJ (Hsp40) homolog, subfamily B, member 1 |
chr1_-_155532484 | 0.55 |
ENST00000368346.3
ENST00000548830.1 |
ASH1L
|
ash1 (absent, small, or homeotic)-like (Drosophila) |
chr1_+_178062855 | 0.54 |
ENST00000448150.3
|
RASAL2
|
RAS protein activator like 2 |
chr6_+_43265992 | 0.51 |
ENST00000449231.1
ENST00000372589.3 ENST00000372585.5 |
SLC22A7
|
solute carrier family 22 (organic anion transporter), member 7 |
chr10_-_30024716 | 0.51 |
ENST00000375398.2
ENST00000375400.3 |
SVIL
|
supervillin |
chr10_+_104678032 | 0.50 |
ENST00000369878.4
ENST00000369875.3 |
CNNM2
|
cyclin M2 |
chr2_-_73053126 | 0.50 |
ENST00000272427.6
ENST00000410104.1 |
EXOC6B
|
exocyst complex component 6B |
chr3_+_49591881 | 0.50 |
ENST00000296452.4
|
BSN
|
bassoon presynaptic cytomatrix protein |
chr17_-_47841485 | 0.49 |
ENST00000506156.1
ENST00000240364.2 |
FAM117A
|
family with sequence similarity 117, member A |
chr12_+_103981044 | 0.48 |
ENST00000388887.2
|
STAB2
|
stabilin 2 |
chr19_-_40324255 | 0.45 |
ENST00000593685.1
ENST00000600611.1 |
DYRK1B
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B |
chr15_+_77287426 | 0.44 |
ENST00000558012.1
ENST00000267939.5 ENST00000379595.3 |
PSTPIP1
|
proline-serine-threonine phosphatase interacting protein 1 |
chr2_+_97481974 | 0.42 |
ENST00000377060.3
ENST00000305510.3 |
CNNM3
|
cyclin M3 |
chr2_-_25873079 | 0.41 |
ENST00000496972.2
|
DTNB
|
dystrobrevin, beta |
chr10_+_111767720 | 0.40 |
ENST00000356080.4
ENST00000277900.8 |
ADD3
|
adducin 3 (gamma) |
chr2_-_69870835 | 0.38 |
ENST00000409085.4
ENST00000406297.3 |
AAK1
|
AP2 associated kinase 1 |
chr2_-_206950781 | 0.38 |
ENST00000403263.1
|
INO80D
|
INO80 complex subunit D |
chr11_-_118047376 | 0.37 |
ENST00000278947.5
|
SCN2B
|
sodium channel, voltage-gated, type II, beta subunit |
chr17_+_14204389 | 0.37 |
ENST00000360954.2
|
HS3ST3B1
|
heparan sulfate (glucosamine) 3-O-sulfotransferase 3B1 |
chr6_+_114178512 | 0.37 |
ENST00000368635.4
|
MARCKS
|
myristoylated alanine-rich protein kinase C substrate |
chr9_-_113342160 | 0.37 |
ENST00000401783.2
ENST00000374461.1 |
SVEP1
|
sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1 |
chr16_-_23521710 | 0.36 |
ENST00000562117.1
ENST00000567468.1 ENST00000562944.1 ENST00000309859.4 |
GGA2
|
golgi-associated, gamma adaptin ear containing, ARF binding protein 2 |
chr19_+_3359561 | 0.36 |
ENST00000589123.1
ENST00000346156.5 ENST00000395111.3 ENST00000586919.1 |
NFIC
|
nuclear factor I/C (CCAAT-binding transcription factor) |
chr3_-_114790179 | 0.36 |
ENST00000462705.1
|
ZBTB20
|
zinc finger and BTB domain containing 20 |
chr9_+_79074068 | 0.36 |
ENST00000444201.2
ENST00000376730.4 |
GCNT1
|
glucosaminyl (N-acetyl) transferase 1, core 2 |
chr12_-_42538657 | 0.35 |
ENST00000398675.3
|
GXYLT1
|
glucoside xylosyltransferase 1 |
chr12_+_8234807 | 0.34 |
ENST00000339754.5
|
NECAP1
|
NECAP endocytosis associated 1 |
chr8_-_38853990 | 0.34 |
ENST00000456845.2
ENST00000397070.2 ENST00000517872.1 ENST00000412303.1 ENST00000456397.2 |
TM2D2
|
TM2 domain containing 2 |
chr7_+_31092076 | 0.33 |
ENST00000304166.4
|
ADCYAP1R1
|
adenylate cyclase activating polypeptide 1 (pituitary) receptor type I |
chr19_-_38806560 | 0.33 |
ENST00000591755.1
ENST00000337679.8 ENST00000339413.6 |
YIF1B
|
Yip1 interacting factor homolog B (S. cerevisiae) |
chr17_-_46623441 | 0.32 |
ENST00000330070.4
|
HOXB2
|
homeobox B2 |
chr12_-_53625958 | 0.31 |
ENST00000327550.3
ENST00000546717.1 ENST00000425354.2 ENST00000394426.1 |
RARG
|
retinoic acid receptor, gamma |
chr11_-_62572901 | 0.30 |
ENST00000439713.2
ENST00000531131.1 ENST00000530875.1 ENST00000531709.2 ENST00000294172.2 |
NXF1
|
nuclear RNA export factor 1 |
chr7_+_142985308 | 0.30 |
ENST00000310447.5
|
CASP2
|
caspase 2, apoptosis-related cysteine peptidase |
chr18_-_60987220 | 0.30 |
ENST00000398117.1
|
BCL2
|
B-cell CLL/lymphoma 2 |
chr12_-_54673871 | 0.29 |
ENST00000209875.4
|
CBX5
|
chromobox homolog 5 |
chr13_+_73632897 | 0.28 |
ENST00000377687.4
|
KLF5
|
Kruppel-like factor 5 (intestinal) |
chr20_-_48099182 | 0.28 |
ENST00000371741.4
|
KCNB1
|
potassium voltage-gated channel, Shab-related subfamily, member 1 |
chr12_+_2162447 | 0.28 |
ENST00000335762.5
ENST00000399655.1 |
CACNA1C
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
chr9_+_90112741 | 0.27 |
ENST00000469640.2
|
DAPK1
|
death-associated protein kinase 1 |
chr6_-_91296602 | 0.27 |
ENST00000369325.3
ENST00000369327.3 |
MAP3K7
|
mitogen-activated protein kinase kinase kinase 7 |
chr14_+_77228532 | 0.27 |
ENST00000167106.4
ENST00000554237.1 |
VASH1
|
vasohibin 1 |
chr11_-_67236691 | 0.26 |
ENST00000544903.1
ENST00000308022.2 ENST00000393877.3 ENST00000452789.2 |
TMEM134
|
transmembrane protein 134 |
chr1_+_87794150 | 0.26 |
ENST00000370544.5
|
LMO4
|
LIM domain only 4 |
chr10_+_105253661 | 0.25 |
ENST00000369780.4
|
NEURL
|
neuralized E3 ubiquitin protein ligase 1 |
chr8_-_37756972 | 0.25 |
ENST00000330843.4
ENST00000522727.1 ENST00000287263.4 |
RAB11FIP1
|
RAB11 family interacting protein 1 (class I) |
chr8_-_18871159 | 0.25 |
ENST00000327040.8
ENST00000440756.2 |
PSD3
|
pleckstrin and Sec7 domain containing 3 |
chr19_-_46234119 | 0.24 |
ENST00000317683.3
|
FBXO46
|
F-box protein 46 |
chrX_-_48824793 | 0.24 |
ENST00000376477.1
|
KCND1
|
potassium voltage-gated channel, Shal-related subfamily, member 1 |
chr2_-_9143786 | 0.24 |
ENST00000462696.1
ENST00000305997.3 |
MBOAT2
|
membrane bound O-acyltransferase domain containing 2 |
chr2_+_120517174 | 0.24 |
ENST00000263708.2
|
PTPN4
|
protein tyrosine phosphatase, non-receptor type 4 (megakaryocyte) |
chr5_-_147162078 | 0.23 |
ENST00000507386.1
|
JAKMIP2
|
janus kinase and microtubule interacting protein 2 |
chr20_+_56964169 | 0.22 |
ENST00000475243.1
|
VAPB
|
VAMP (vesicle-associated membrane protein)-associated protein B and C |
chr1_-_186649543 | 0.21 |
ENST00000367468.5
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
chr9_-_20622478 | 0.21 |
ENST00000355930.6
ENST00000380338.4 |
MLLT3
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3 |
chr12_+_12764773 | 0.21 |
ENST00000228865.2
|
CREBL2
|
cAMP responsive element binding protein-like 2 |
chr12_+_60083118 | 0.21 |
ENST00000261187.4
ENST00000543448.1 |
SLC16A7
|
solute carrier family 16 (monocarboxylate transporter), member 7 |
chr3_-_37034702 | 0.21 |
ENST00000322716.5
|
EPM2AIP1
|
EPM2A (laforin) interacting protein 1 |
chr12_-_117319236 | 0.21 |
ENST00000257572.5
|
HRK
|
harakiri, BCL2 interacting protein (contains only BH3 domain) |
chr2_-_85839146 | 0.20 |
ENST00000306336.5
ENST00000409734.3 |
C2orf68
|
chromosome 2 open reading frame 68 |
chr19_-_47128294 | 0.19 |
ENST00000596260.1
ENST00000597185.1 ENST00000598865.1 ENST00000594275.1 ENST00000291294.2 |
PTGIR
|
prostaglandin I2 (prostacyclin) receptor (IP) |
chr8_-_82024290 | 0.18 |
ENST00000220597.4
|
PAG1
|
phosphoprotein associated with glycosphingolipid microdomains 1 |
chr17_+_61086917 | 0.17 |
ENST00000424789.2
ENST00000389520.4 |
TANC2
|
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2 |
chr15_+_68871308 | 0.16 |
ENST00000261861.5
|
CORO2B
|
coronin, actin binding protein, 2B |
chr12_-_65146636 | 0.16 |
ENST00000418919.2
|
GNS
|
glucosamine (N-acetyl)-6-sulfatase |
chr10_+_11206925 | 0.16 |
ENST00000354440.2
ENST00000315874.4 ENST00000427450.1 |
CELF2
|
CUGBP, Elav-like family member 2 |
chr20_-_41818373 | 0.15 |
ENST00000373187.1
ENST00000356100.2 ENST00000373184.1 ENST00000373190.1 |
PTPRT
|
protein tyrosine phosphatase, receptor type, T |
chr1_-_154155595 | 0.15 |
ENST00000328159.4
ENST00000368531.2 ENST00000323144.7 ENST00000368533.3 ENST00000341372.3 |
TPM3
|
tropomyosin 3 |
chr6_+_132129151 | 0.15 |
ENST00000360971.2
|
ENPP1
|
ectonucleotide pyrophosphatase/phosphodiesterase 1 |
chr11_+_76494253 | 0.13 |
ENST00000333090.4
|
TSKU
|
tsukushi, small leucine rich proteoglycan |
chrX_+_73641286 | 0.12 |
ENST00000587091.1
|
SLC16A2
|
solute carrier family 16, member 2 (thyroid hormone transporter) |
chr1_+_2323260 | 0.11 |
ENST00000378518.1
ENST00000605895.1 ENST00000378513.3 ENST00000306256.9 ENST00000378512.1 |
RER1
|
retention in endoplasmic reticulum sorting receptor 1 |
chrX_+_69664706 | 0.10 |
ENST00000194900.4
ENST00000374360.3 |
DLG3
|
discs, large homolog 3 (Drosophila) |
chr2_+_86947296 | 0.09 |
ENST00000283632.4
|
RMND5A
|
required for meiotic nuclear division 5 homolog A (S. cerevisiae) |
chr5_-_126366500 | 0.09 |
ENST00000308660.5
|
MARCH3
|
membrane-associated ring finger (C3HC4) 3, E3 ubiquitin protein ligase |
chr19_-_47735918 | 0.09 |
ENST00000449228.1
ENST00000300880.7 ENST00000341983.4 |
BBC3
|
BCL2 binding component 3 |
chr17_+_38219063 | 0.08 |
ENST00000584985.1
ENST00000264637.4 ENST00000450525.2 |
THRA
|
thyroid hormone receptor, alpha |
chr5_+_54455946 | 0.07 |
ENST00000503787.1
ENST00000296734.6 ENST00000515370.1 |
GPX8
|
glutathione peroxidase 8 (putative) |
chr13_+_25946201 | 0.06 |
ENST00000381655.2
|
ATP8A2
|
ATPase, aminophospholipid transporter, class I, type 8A, member 2 |
chr11_-_77532050 | 0.05 |
ENST00000308488.6
|
RSF1
|
remodeling and spacing factor 1 |
chr2_+_220042933 | 0.04 |
ENST00000430297.2
|
FAM134A
|
family with sequence similarity 134, member A |
chr3_-_179754706 | 0.04 |
ENST00000465751.1
ENST00000467460.1 |
PEX5L
|
peroxisomal biogenesis factor 5-like |
chr20_-_62284766 | 0.04 |
ENST00000370053.1
|
STMN3
|
stathmin-like 3 |
chr1_-_217262969 | 0.04 |
ENST00000361525.3
|
ESRRG
|
estrogen-related receptor gamma |
chr11_+_66025167 | 0.03 |
ENST00000394067.2
ENST00000316924.5 ENST00000421552.1 ENST00000394078.1 |
KLC2
|
kinesin light chain 2 |
chr15_+_67358163 | 0.03 |
ENST00000327367.4
|
SMAD3
|
SMAD family member 3 |
chr7_-_128695147 | 0.02 |
ENST00000482320.1
ENST00000393245.1 ENST00000471234.1 |
TNPO3
|
transportin 3 |
chr1_+_27153173 | 0.02 |
ENST00000374142.4
|
ZDHHC18
|
zinc finger, DHHC-type containing 18 |
chr1_+_51701924 | 0.02 |
ENST00000242719.3
|
RNF11
|
ring finger protein 11 |
chr3_-_125094093 | 0.01 |
ENST00000484491.1
ENST00000492394.1 ENST00000471196.1 ENST00000468369.1 ENST00000544464.1 ENST00000485866.1 ENST00000360647.4 |
ZNF148
|
zinc finger protein 148 |
chr12_-_49449107 | 0.01 |
ENST00000301067.7
|
KMT2D
|
lysine (K)-specific methyltransferase 2D |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 3.3 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
1.1 | 5.3 | GO:0098728 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) positive regulation of NK T cell differentiation(GO:0051138) germline stem cell asymmetric division(GO:0098728) |
0.7 | 3.0 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.7 | 5.6 | GO:0070236 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.6 | 1.9 | GO:1904204 | regulation of skeletal muscle hypertrophy(GO:1904204) |
0.6 | 1.7 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.5 | 3.9 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.5 | 1.8 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.4 | 1.1 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.3 | 1.0 | GO:0046619 | optic placode formation involved in camera-type eye formation(GO:0046619) |
0.3 | 0.9 | GO:0072275 | metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
0.3 | 0.9 | GO:0002605 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) negative regulation of dendritic cell antigen processing and presentation(GO:0002605) |
0.3 | 1.1 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.3 | 1.7 | GO:0007296 | vitellogenesis(GO:0007296) |
0.3 | 0.8 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.2 | 0.7 | GO:0008050 | female courtship behavior(GO:0008050) |
0.2 | 0.9 | GO:0090210 | vitamin E metabolic process(GO:0042360) regulation of establishment of blood-brain barrier(GO:0090210) negative regulation of establishment of blood-brain barrier(GO:0090212) |
0.2 | 0.7 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.2 | 2.2 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.2 | 0.8 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.2 | 1.0 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) cellular response to vitamin E(GO:0071306) response to fluoride(GO:1902617) |
0.2 | 1.3 | GO:0043634 | polyadenylation-dependent ncRNA catabolic process(GO:0043634) |
0.2 | 1.0 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) |
0.2 | 0.7 | GO:0030242 | pexophagy(GO:0030242) |
0.1 | 0.6 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.1 | 1.2 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.1 | 0.5 | GO:0097676 | histone H3-K36 dimethylation(GO:0097676) |
0.1 | 1.4 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.1 | 1.4 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.1 | 0.9 | GO:0044351 | macropinocytosis(GO:0044351) |
0.1 | 0.3 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.1 | 0.3 | GO:0003431 | growth plate cartilage chondrocyte growth(GO:0003430) growth plate cartilage chondrocyte development(GO:0003431) |
0.1 | 0.7 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.1 | 0.6 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.1 | 1.0 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 0.3 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.1 | 1.3 | GO:0002158 | osteoclast proliferation(GO:0002158) |
0.1 | 0.7 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.1 | 1.4 | GO:0044804 | nucleophagy(GO:0044804) |
0.1 | 0.3 | GO:0043375 | negative regulation of cellular pH reduction(GO:0032848) CD8-positive, alpha-beta T cell lineage commitment(GO:0043375) negative regulation of retinal cell programmed cell death(GO:0046671) |
0.1 | 0.2 | GO:0031394 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.1 | 0.3 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.1 | 0.4 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.1 | 1.3 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 2.9 | GO:0010863 | positive regulation of phospholipase C activity(GO:0010863) |
0.0 | 1.3 | GO:0045332 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.0 | 0.3 | GO:0035234 | luteolysis(GO:0001554) ectopic germ cell programmed cell death(GO:0035234) |
0.0 | 0.1 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.0 | 1.9 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.0 | 0.3 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.0 | 0.6 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.0 | 0.3 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) |
0.0 | 1.5 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.0 | 0.5 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
0.0 | 0.7 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.0 | 1.2 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.0 | 1.9 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.0 | 0.4 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.0 | 1.0 | GO:0021522 | spinal cord motor neuron differentiation(GO:0021522) |
0.0 | 0.2 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.0 | 0.9 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.0 | 0.8 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.0 | 0.2 | GO:1901475 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.0 | 0.3 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.0 | 0.2 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.0 | 1.2 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
0.0 | 0.2 | GO:0007379 | segment specification(GO:0007379) |
0.0 | 0.1 | GO:0072501 | cellular phosphate ion homeostasis(GO:0030643) negative regulation of glycogen biosynthetic process(GO:0045719) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.0 | 0.5 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.0 | 0.2 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.0 | 0.4 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.0 | 1.3 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.3 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.0 | 0.6 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.3 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.0 | 0.3 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.0 | 0.4 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.0 | 0.2 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 0.4 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
0.0 | 0.2 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.0 | 0.4 | GO:0060612 | adipose tissue development(GO:0060612) |
0.0 | 0.2 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 3.3 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.5 | 1.4 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
0.2 | 0.6 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.2 | 1.9 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.1 | 0.8 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 1.0 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.1 | 0.7 | GO:1990635 | proximal dendrite(GO:1990635) |
0.1 | 3.9 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.1 | 0.5 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.1 | 1.0 | GO:0001741 | XY body(GO:0001741) |
0.1 | 0.9 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 1.3 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.1 | 0.7 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 6.2 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 0.8 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 0.9 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 2.2 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.0 | 2.0 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.0 | 0.1 | GO:0034657 | GID complex(GO:0034657) |
0.0 | 0.5 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 1.1 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 0.4 | GO:0043073 | germ cell nucleus(GO:0043073) |
0.0 | 0.5 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.4 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.0 | 0.3 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.0 | 0.3 | GO:0000346 | transcription export complex(GO:0000346) nuclear inclusion body(GO:0042405) |
0.0 | 1.1 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.4 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.0 | 1.8 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
0.0 | 2.2 | GO:0016605 | PML body(GO:0016605) |
0.0 | 0.0 | GO:0031213 | RSF complex(GO:0031213) |
0.0 | 1.3 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.0 | 0.3 | GO:0046930 | pore complex(GO:0046930) |
0.0 | 0.5 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.0 | 1.0 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 1.6 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.0 | 0.9 | GO:0035580 | specific granule lumen(GO:0035580) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 5.6 | GO:0043426 | MRF binding(GO:0043426) |
0.5 | 5.3 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.3 | 1.4 | GO:0035276 | ethanol binding(GO:0035276) |
0.3 | 0.9 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.3 | 0.9 | GO:0070052 | collagen V binding(GO:0070052) |
0.3 | 1.4 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.2 | 0.9 | GO:0008431 | vitamin E binding(GO:0008431) |
0.2 | 0.7 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.2 | 1.3 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.2 | 0.8 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.2 | 1.0 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.2 | 1.2 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.2 | 1.0 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.2 | 1.3 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.2 | 1.8 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.2 | 1.4 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.1 | 1.7 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.1 | 2.9 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 0.4 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.1 | 0.7 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.1 | 2.2 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.1 | 1.8 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 1.0 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.1 | 0.6 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.1 | 1.0 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 3.9 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.1 | 1.1 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.1 | 0.4 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.1 | 0.2 | GO:0033149 | FFAT motif binding(GO:0033149) |
0.1 | 0.7 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 0.3 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 0.5 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.1 | 3.3 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.1 | 0.9 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.1 | 0.3 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.1 | 0.9 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.1 | 0.4 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.1 | 0.5 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.1 | 1.1 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 0.2 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) arachidonate 15-lipoxygenase activity(GO:0050473) |
0.1 | 0.2 | GO:0005477 | pyruvate secondary active transmembrane transporter activity(GO:0005477) |
0.1 | 1.3 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.1 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.0 | 3.9 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 0.2 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.0 | 0.5 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 0.4 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 0.2 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.0 | 0.2 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.0 | 0.2 | GO:0047144 | 2-acylglycerol-3-phosphate O-acyltransferase activity(GO:0047144) |
0.0 | 0.7 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.4 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.0 | 0.3 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.0 | 1.2 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.8 | GO:0043394 | proteoglycan binding(GO:0043394) |
0.0 | 1.0 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.0 | 0.4 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.0 | 0.6 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.0 | 1.3 | GO:0097110 | scaffold protein binding(GO:0097110) |
0.0 | 0.5 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.0 | 0.7 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.1 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.0 | 0.3 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.0 | 0.7 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.2 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.0 | 1.1 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 0.3 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.0 | 0.8 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.0 | 5.8 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.0 | 0.9 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 2.9 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 1.4 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 1.4 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 0.6 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 0.7 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 1.6 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.9 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 1.3 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 1.9 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 1.4 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 0.8 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 1.7 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.0 | 1.1 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 1.7 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 1.8 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 1.3 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.9 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 1.2 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 3.8 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.3 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.7 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 0.8 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.2 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 2.9 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.1 | 1.9 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 2.2 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 1.0 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 0.9 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.1 | 0.8 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 0.3 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.0 | 3.9 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.7 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.0 | 1.1 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.0 | 1.4 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 0.4 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 1.4 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 2.0 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.0 | 1.1 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.4 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.0 | 1.1 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.5 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.0 | 1.2 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 0.3 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.3 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.0 | 0.5 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.9 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.0 | 1.3 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 1.0 | REACTOME NEGATIVE REGULATION OF FGFR SIGNALING | Genes involved in Negative regulation of FGFR signaling |
0.0 | 0.3 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.0 | 2.3 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.6 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.8 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 1.0 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 0.2 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.0 | 0.3 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.0 | 1.6 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.0 | 1.9 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.2 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 1.1 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.4 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.2 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.4 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |